PTC Therapeutics (PTCT) Moves 7.2% Higher: Will This Strength Last?
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics Announces Pricing of Convertible Notes Offering to Refinance 2026 Convertible Notes
PTC Therapeutics Announces Pricing of Convertible Notes Offering to Refinance 2026 Convertible Notes
PTC Therapeutics Announces Proposed Convertible Notes Offering to Refinance 2026 Convertible Notes
PTC Therapeutics, Inc. (PTCT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
PTC Therapeutics, Inc. (PTCT) Presents at Bank of America Global Healthcare Conference 2026 Transcript
PTC Therapeutics: Sephience Turns The Story From Regulatory Repair To Operating Leverage
PTC Therapeutics Q1 Earnings Call Highlights
PTC Therapeutics, Inc. (PTCT) Q1 2026 Earnings Call Transcript
Compared to Estimates, PTC Therapeutics (PTCT) Q1 Earnings: A Look at Key Metrics
PTC Therapeutics (PTCT) Reports Q1 Loss, Tops Revenue Estimates
PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results
Exploring Analyst Estimates for PTC Therapeutics (PTCT) Q1 Earnings, Beyond Revenue and EPS
PTC Therapeutics to Participate in Upcoming Investor Conferences
PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
PTC Therapeutics, Inc. (PTCT) Discusses 24-Month Interim Results of PIVOT-HD Long-Term Extension Study of Votoplam in Huntington's Disease Transcript
PTC Therapeutics Stock Sinks As Pivotal Data Fails To Calm Sellers
PTC Therapeutics Reports Positive Topline Results from Month 24 Interim Analysis of PIVOT-HD Extension Study of Votoplam
PTC Therapeutics to Report Results from PIVOT-HD Long Term Extension Study
Abacus FCF Advisors LLC Makes New $5.76 Million Investment in PTC Therapeutics, Inc. $PTCT
PTC Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Burney Co. Takes Position in PTC Therapeutics, Inc. $PTCT
PTC Therapeutics (NASDAQ:PTCT) EVP Lee Scott Golden Sells 829 Shares
Phocas Financial Corp. Has $1.94 Million Stock Position in PTC Therapeutics, Inc. $PTCT
Neil Gregory Almstead Sells 52,003 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock
PTC Therapeutics, Inc. $PTCT Shares Sold by Assenagon Asset Management S.A.
PTC Therapeutics Appoints Biotech Banking Pioneer Jessica Chutter to Board of Directors
Critical Contrast: PTC Therapeutics (NASDAQ:PTCT) & Axsome Therapeutics (NASDAQ:AXSM)
Cinctive Capital Management LP Takes Position in PTC Therapeutics, Inc. $PTCT
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (PTCT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
PTC Therapeutics, Inc. (PTCT) Presents at Leerink Global Healthcare Conference 2026 Transcript
Investment Manager Bets Big on PTCT Stock, Adds 41,000 Shares, According to Recent SEC Filing
PTC Therapeutics, Inc. (NASDAQ:PTCT) Given Consensus Rating of “Moderate Buy” by Analysts
Mark Elliott Boulding Sells 3,019 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock
PTC Therapeutics to Participate at Upcoming Investor Conferences
PTC Therapeutics: Sephience As A Major Growth Driver
PTC Therapeutics (NASDAQ:PTCT) CAO Sells $172,983.84 in Stock
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) EVP Sells $172,290.24 in Stock
Matthew Klein Sells 7,371 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock
19,142 Shares in PTC Therapeutics, Inc. $PTCT Acquired by Brummer Multi Strategy AB
PTC Therapeutics, Inc. (PTCT) Q4 2025 Earnings Call Transcript
PTC Therapeutics (PTCT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
PTC Therapeutics (PTCT) Reports Q4 Loss, Misses Revenue Estimates
PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Ahead of PTC Therapeutics (PTCT) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
PTC Therapeutics Provides Regulatory Update on Translarna™
PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release